Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients.

Source:http://linkedlifedata.com/resource/pubmed/id/11899654

Download in:

View as

General Info

PMID
11899654